The Global Resource For Connecting Buyers and Sellers

Prometic granted orphan drug designation by FDA for Inter-Alpha-Inhibitor-Proteins for treatment of necrotizing enterocolitis (NEC)

Additional orphan drug designation added to growing portfolio of unique plasma-derived therapeutics
NEC is the most common acquired gastrointestinal disease in premature neonates and one of the leading causes of death in neonatal intensive care units
The economic cost of…